Testing a new eye drop for fungal eye infections
Part of Eyes & vision clinical trials.
This trial tests a new eye drop called IVIEW-1201 to see if it works as well as the current standard treatment for fungal keratitis, a serious infection of the cornea. If you have a fungal eye infection confirmed by a lab test and have not used antifungal medications in the last two days, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a fungal infection in your eye confirmed by a lab test.
- You must not have used any antifungal eye drops or pills in the last 48 hours.
- You must be willing to attend all study visits and follow the procedures.
- You must not have other serious eye problems like a hole in your cornea or glaucoma.
- You cannot be pregnant, planning to become pregnant, or breastfeeding during the study.
- You must not have used steroid eye drops in the last 3 days or steroid pills in the last 14 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding cyclosporine A to the standard natamycin eye drops can better treat fungal eye infections. It may help people with moderate vision loss from a fungal corneal infection.
This trial tests a medical device eye ointment called Vit-A-Vision for people with dry eye disease. It aims to see if the ointment can improve symptoms and tear film stability over about a month.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
This trial tests whether a new eye drop called Lacripep can help treat neurotrophic keratitis, a rare eye condition where the cornea loses sensation and can become damaged. The study compares Lacripep to a placebo (inactive) drop to see if it improves corneal healing and vision.
This study tests a new light-based treatment for a rare fungal infection of the eye (Fusarium keratitis) that can cause vision loss. It aims to see if this therapy can fight the infection and help preserve or improve your vision.
This study tests a new, non-invasive (no needles or surgery) way to diagnose a type of eye infection called microbial keratitis. It may help find the cause faster so you get the right treatment sooner.
Hear when a new Fungal Keratitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.